Trametinib’s job is to block MEK, which is used to treat melanoma with BRAF V600E/K mutations and NSCLC. It stops MEK signaling in its tracks. You’re supposed to take 2 mg of it every day on an empty stomach.
There are two types of tablets: 0.5 mg and 2 mg. These tablets are coated and come in bottles with 30 of them. Trametinib is known for its effectiveness in inhibiting the MEK enzyme, which is a key component in the MAPK signaling pathway in cells.
By stopping this pathway, trametinib can stop cancer cells from growing and shrink tumors. The coated tablets are made to be easier to take and for patients to stick with the treatment. It’s simple – just one pill a day.
It makes it easier for both patients and doctors to manage. They also made it so it doesn’t cause as many tummy troubles, which is a big deal with cancer drugs.
